|
End
of a pipe dream
Industry stalwarts awaited the announcement of this union
budget, but when the FM unfurled his offerings, little seemed
to have emerged for the pharma industry besides the reduction
of duties on life-saving drugs and rationalisation of FBT.
Deepali Gupta explores what lies beneath
A
‘Made in India’ blockbuster
Biocon started 28 years ago, with an initial capital of Rs
10,000, in her garage. Often paralleled to Narayana Murthy
of Infosys in the Indian biotech industry, today Kiran Mazumdar
Shaw, a path breaker and pioneer, has established herself
as a model employer and a visionary, who inspires the next
generation of entrepreneurs. Deepali Gupta and Kumar Dawada
explore what she says about the future of biotechnology in
India
Kemwell
acquires a Pfizer manufacturing facility in Sweden
Kemwell, an Indian contract manufacturer, has acquired Pfizer's
manufacturing plant in Uppsala, Sweden, for an undisclosed
amount. Kemwell will continue to manufacture the anti-inflammatory
drug Salazopyrine. Zeibrant Lindqvist, CEO, Pfizer Health
AB, says, “By selling the production facility, we believe
that the plant and jobs will remain in the region.”
Anemone
Pharmaceuticals announce plans to expand reach
With a mission to cover India from Kashmir to Kanyakumari,
the Director of Anemone Pharmaceuticals, S Mahesh said, “Although
we have suffered a small setback in this year's budget, in
the financial year 2006-07, we intend to expand operations
to an estimated Rs 50 crore.”
Revolutionary
Stem Cell technology now available in Surat
LifeCell, India's cord blood bank, announced the launch of
its marketing and collection centre in Surat, for umbilical
cord stem cell banking. LifeCell has a Stem Cell Processing
and Banking facility near Chennai, conforming to the standards
of American Association of Blood Banks and USFDA.
Wyeth
sorts out Prevenar mess
Following a major controversy that sparked off from the earlier
announcement of Wyeth to relinquish its marketing rights for
Prevenar vaccine, there is yet another news about Wyeth, the
51 percent Indian subsidiary of Wyeth USA, retaining the marketing
rights for the vaccine.
Lupin
leaves Thailand and moves to South Africa
Lupin and Aspen Pharma-care Holdings, South Africa, have entered
into a Memorandum of Under-standing for the establishment.
The MOU is a 50:50 joint venture for the development, manufacture
and global marketing (except US, South Africa & India
Trade) of selected Anti-TB products.
Baxter
supports earthquake victims in India and Pakistan
Baxter International has announced its donation of more than
280,000 doses of the company's NeisVac-C vaccine, a meningococcal
group C vaccine, to International Health Partners (IHP).
Stock
Watch
Formulating
the winning strategies
No readymade formulae that were distributed or universal cure
suggested. Globalisation strategies for emerging corporates,
focusing on pharmaceutical industry organised by Citygroup
at the hotel Taj came through as a platform to provoke thinking
among the emerging stars of the Indian pharmaceutical space.
World
Nano-Economic Congress India
The pharmaceutical and biotech industries are in the front
ranks of India's science-based industries, with wide ranging
capabilities in the complex field of drug manufacture and
technology.
Pharma
bets big on branding!
Its not just Coca-Cola, Surf or Maggie that move consumers
to action and boast of their brand supremacy, all the pharma
products are betting big on branding. As a testimonial to
the increasing brand awareness in the pharma world, IBC Asia
(S) Pte organised a conference on 'Pharma Branding and Marketing'
on the 23 and 24 of February, 2006 at Taj Lands End Hotel,
Mumbai.
Some
heavy talk on Ayurveda!
The JAMA report, the Canadian ban and heavy publicity on the
harm of heavy metals is what Ayurveda is in news for. And
certainly, it is no good news for the ayurvedic practitioners.
Indian Drug Manufacturers' Association (IDMA) and Ayurvedic
Drug Manufacturers' Association (ADMA) have turned in to do
some serious damage control.
Cleaning
validation, an evolving topic
Validation of cleaning processes is a hot topic of discussion
in Pharma vicinity these days, especially with rising number
of Indian manufacturing units going for USFDA and MHRA approvals.
The three-day workshop on cleaning validation was pivotal
in bringing out the cleaning validation related issues and
providing the practical training to solve them.
|
